Literature DB >> 9048236

The influence of endometriosis on the success of gamete intrafallopian transfer (GIFT).

M Y Chang1, C H Chiang, T T Hsieh, Y K Soong, K H Hsu.   

Abstract

PURPOSE: Our purpose was to evaluate the outcomes of gamete intrafallopian transfer (GIFT) therapy in patients with endometriosis.
METHODS: One hundred eight GIFT cycles performed under the indication of endometriosis were compared to 156 GIFT cycles with indications of other disease entities. A maximum of seven oocytes was transferred into one or both fimbriate ends with prepared spermatozoa. Clinical pregnancy rates and outcomes were evaluated according to Mantel-Haenszel's chi-square test. Multiple logistic regression analysis was performed to determine factors influencing the success on pregnancy in the total treatment cycles.
RESULTS: The anthropological variables, such as age of patients, duration of infertility, and semen grading, were comparable in both groups. The responses to controlled ovarian hyperstimulation (COH) were progressively decreased while increasing the severity of endometriosis conditions such as nonendometriosis, mild-form endometriosis, and advanced-form endometriosis patients. However, there were no significant differences in the clinical pregnancy rates (40.4, 36.7, and 41.7%, respectively), multiple pregnancy rates (34.9, 27.3, and 45.0%, respectively), and early pregnancy loss rates (27.0, 18.2, and 30.0%, respectively). Multivariate statistics of pregnancy rates that adjusted the effects of patients' age, tubal health, presence of active endometriosis and/or endometriomas, number of oocytes transferred, and quality of sperm exhibited no statistical significance between endometriosis and nonendometriosis groups.
CONCLUSIONS: Our data show that patients with records of endometriosis have both a decreased ovarian response to gonadotropin stimulation and a decreased number of retrieved oocytes. Since the number of oocytes needed for the GIFT procedure is limited, pregnancy results for patients in the study group were comparable with those for patients in the control group.

Entities:  

Mesh:

Year:  1997        PMID: 9048236      PMCID: PMC3454826          DOI: 10.1007/bf02765774

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  14 in total

1.  The treatment of infertility associated with endometriosis by in vitro fertilization.

Authors:  P L Matson; J L Yovich
Journal:  Fertil Steril       Date:  1986-09       Impact factor: 7.329

2.  The role of in vitro fertilization in infertile patients with endometriosis.

Authors:  C F Chillik; A A Acosta; J E Garcia; S Perera; J F Van Uem; Z Rosenwaks; H W Jones
Journal:  Fertil Steril       Date:  1985-07       Impact factor: 7.329

Review 3.  Endometriosis: a reappraisal of pathogenesis and treatment.

Authors:  C L Schmidt
Journal:  Fertil Steril       Date:  1985-08       Impact factor: 7.329

4.  Revised American Fertility Society classification of endometriosis: 1985.

Authors: 
Journal:  Fertil Steril       Date:  1985-03       Impact factor: 7.329

5.  Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis.

Authors:  K Nakamura; M Oosawa; I Kondou; S Inagaki; H Shibata; O Narita; N Suganuma; Y Tomoda
Journal:  J Assist Reprod Genet       Date:  1992-04       Impact factor: 3.412

6.  Endometriosis and ovulatory disorder: reduced fertilisation in vitro compared with tubal and unexplained infertility.

Authors:  P G Wardle; J D Mitchell; E A McLaughlin; B D Ray; A McDermott; M G Hull
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

7.  Results of IVF in patients with endometriosis: the severity of the disease does not affect outcome, or the incidence of miscarriage.

Authors:  S Geber; T Paraschos; G Atkinson; R Margara; R M Winston
Journal:  Hum Reprod       Date:  1995-06       Impact factor: 6.918

8.  The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates.

Authors:  W P Dmowski; N Rana; J Michalowska; J Friberg; C Papierniak; A el-Roeiy
Journal:  Fertil Steril       Date:  1995-03       Impact factor: 7.329

9.  Cost-effectiveness of gamete intrafallopian transfer in comparison with induction of ovulation with gonadotropins in the treatment of female infertility: a clinical trial.

Authors:  P H Wessels; H S Cronjé; A P Oosthuizen; M D Trümpelmann; S Grobler; D K Hamlett
Journal:  Fertil Steril       Date:  1992-01       Impact factor: 7.329

10.  The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer.

Authors:  D Dicker; J A Goldman; T Levy; D Feldberg; J Ashkenazi
Journal:  Fertil Steril       Date:  1992-03       Impact factor: 7.329

View more
  1 in total

1.  Antral follicle counting in predicting the retrieved oocyte number after ovarian hyperstimulation.

Authors:  Y Y Hsieh; C C Chang; H D Tsai
Journal:  J Assist Reprod Genet       Date:  2001-06       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.